Related Experiment Video

Updated: Jun 12, 2025

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

10.3K

CITED4 gene therapy: Can it be cited for preventing maladaptive post-ischemic cardiac remodeling?

Henry Nording1, Oliver J Müller1

  • 1Department of Internal Medicine V, University of Kiel, and German Centre for Cardiovascular Research, Partner Site Hamburg/Kiel/Lübeck, Kiel, Germany; DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Lübeck/Kiel, 23562 Lübeck, Germany.

Molecular Therapy : the Journal of the American Society of Gene Therapy
|September 24, 2024
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

12.8K
Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

1.5K

Related Experiment Videos

Last Updated: Jun 12, 2025

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy
11:51

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

10.3K
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
07:35

Gene Transfer for Ischemic Heart Failure in a Preclinical Model

Published on: May 15, 2011

12.8K
Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

1.5K

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K

Articles linked to this work by shared authors, journal, and citation graph.

Learning from Biodegradable Coronary Stents: Future Directions for TPVR Biodegradable Stents.

International journal of molecular sciences·2026

A Novel Pak1 Activator Ameliorates ER Stress for HFpEF Therapy.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Cancer treatment-related cardiovascular toxicity according to the ESC definition in patients receiving CAR T-cell therapy.

Cardio-oncology (London, England)·2026

Advanced therapy medicinal products for local treatment using new delivery methods.

Biochemical pharmacology·2026

Immunomodulatory endothelial cells contribute to T-cell recruitment and activation via antigen presentation on MHC II.

Cardiovascular research·2026

Aortic asprosin overexpression does not ameliorate disease pathophysiology in a murine model of Marfan syndrome.

Scientific reports·2026

Discovery of synthetic TBK1 activator inducing type I interferon mediated antiviral and antitumor immunity.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Healing helminths: The disease-modifying potential of helminth-derived proteins in animal models of inflammatory disease - a systematic review.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

C-terminus CD28 phosphorylation, Y218, modulates IL-2 secretion and therapeutic effect of CAR-T cells.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Targeting EZH2 and EGFR Therapeutic Vulnerabilities of TNBC with a Single Chemical Entity Confers Preclinical Treatment Advantage.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

ACC1 inhibition enhances BCG-induced trained immunity by reprogramming Acetyl-CoA metabolism.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Advanced iPSC-based modelling of LMNA-related congenital muscular dystrophy enables development of genetic therapies for muscle laminopathies.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Machine learning-integrated explainable artificial intelligence for survival prediction in urothelial carcinoma with enfortumab vedotin: an exploratory real-world analysis.

Expert opinion on biological therapy·2026

Pulmonary vein to ganglionated plexi distance predicts cryoballoon ganglionated plexi modification.

Heart rhythm O2·2026

Educational Utility of a Full-Skull 3-Dimensional Model for Skull Base Surgery Training.

Neurosurgery practice·2026

An interpretable multimodal machine learning model integrating transvaginal ultrasound and clinical features for differentiating benign from malignant endometrial thickening in postmenopausal women.

Frontiers in oncology·2026

Performance of multi-strategy optimized mayfly optimization algorithm for location selection of university reimbursement form submission terminals.

Scientific reports·2026

An Improved Rat Model of Myocardial Infarction Without Invasive Intubation.

In vivo (Athens, Greece)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us